Table 3. Cox regression analysis with inclusion of HDAC2 expression (n=145).
Overall survival
|
|||
---|---|---|---|
HR | 95%CI | P-value | |
HDAC2 expression | |||
Low | 1.000 | ||
High | 2.363 | 1.150–4.856 | 0.019 |
Pre-OP PSA | |||
⩽10 ng ml−1 | 1.000 | ||
>10 ng ml−1 | 1.542 | 0.884–2.691 | 0.127 |
Tumour stage | |||
pT2 | 1.000 | ||
pT3/pT4 | 1.557 | 0.830–2.919 | 0.168 |
Gleason sum | |||
2–6 | 1.000 | ||
7 | 2.795 | 1.325–5.898 | 0.007 |
8–10 | 3.131 | 1.403–6.989 | 0.005 |
R-status | |||
R0 | 1.000 | ||
R1 | 1.440 | 0.789–2.631 | 0.235 |
CI=confidence interval; HDAC=histone deacetylase; HR=hazard ratio.